Halobetasol or ulobetasol
- Level
- Commodity
- Parent
- 51421600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51421604This classification denotes a therapeutic glucocorticoid with the molecular formula C22H27ClF2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9P6159HM7T, chemically known as 21-chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate but generally known as halobetasol, which bears US NIH Compound Identifier 48175. European Medicines Agency schedules Halobetasol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11379MIG. World Health Organization schedules halobetasol in its Anatomical Therapeutic Chemical (ATC) Classification. Halobetasol or ulobetasol bears US NLM identifiers UMLS ID C0082787 and NCI Concept Code C61781. SMILES: CLCC(=O)C1(OC(=O)CC)C2(C(C3C(F)(C(O)C2)C2(C(=CC(=O)C=C2)C(F)C3)C)CC1C)C.
Same parent
Under 51421600 · 8Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.